A DOUBLE-BLIND EVALUATION OF ANTIHYPERTENSIVE DRUGS.
D000959:Antihypertensive Agents; D035843:Biomedical Research; D001794:Blood Pressure; D001795:Blood Pressure Determination; D002317:Cardiovascular Agents; D004311:Double-Blind Method; D004876:Ergot Alkaloids; D006145:Guanethidine; D008784:Methysergide; D010600:Pharmacology; D010919:Placebos; D011187:Posture; D012110:Reserpine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D013148:Spironolactone
D000959:Antihypertensive Agents; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D006145:Guanethidine; D008784:Methysergide; D010919:Placebos; D012110:Reserpine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D013148:Spironolactone
ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL RESEARCH; ERGOT ALKALOIDS; GUANETHIDINE; METHYSERGIDE; PHARMACOLOGY; PLACEBOS; POSTURE; RESERPINE; SEROTONIN INHIBITORS; SPIRONOLACTONE